Emory is one of 23 sites involved in the Parkinson's Progression Markers Initiative (PPMI), a research initiative launched in 2010 by the Michael J. Fox Foundation for Parkinson's Research to expand the search for biomarkers for a more efficient diagnosis of Parkinson's disease.